TransCode Therapeutics, Inc.
RNAZ · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5,811 | $2,768 | $4,968 | $20,826 |
| Short-Term Investments | $0 | $0 | $9 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1,282 | $1,679 | $2,402 | $1,906 |
| Total Curr. Assets | $7,093 | $4,455 | $7,379 | $22,732 |
| Property Plant & Equip (Net) | $89 | $602 | $209 | $206 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $112 | $112 | -$0 | -$0 |
| Total NC Assets | $201 | $714 | $209 | $206 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $7,294 | $5,170 | $7,588 | $22,938 |
| Liabilities | – | – | – | – |
| Payables | $2,576 | $0 | $0 | $2,016 |
| Short-Term Debt | $38 | $412 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $27 | $0 | $31 |
| Other Curr. Liab. | $157 | $3,051 | $4,347 | $487 |
| Total Curr. Liab. | $2,772 | $3,491 | $4,347 | $2,534 |
| LT Debt | $0 | $38 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $6,541 | $0 | $0 | $0 |
| Total NC Liab. | $6,541 | $38 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $451 | $0 | $0 |
| Total Liabilities | $9,313 | $3,529 | $4,347 | $2,534 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $1 |
| Retained Earnings | -$63,202 | -$46,416 | -$27,870 | -$10,305 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $61,183 | $48,057 | $31,111 | $30,708 |
| Total Equity | -$2,019 | $1,641 | $3,241 | $20,404 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $7,294 | $5,170 | $7,588 | $22,938 |
| Net Debt | -$5,773 | -$2,317 | -$4,968 | -$20,826 |